ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $999 | +50.0% | 36,805 | +69.9% | 0.02% | +46.2% |
| Q2 2023 | $666 | -14.7% | 21,667 | 0.0% | 0.01% | -23.5% |
| Q1 2023 | $781 | -8.8% | 21,667 | 0.0% | 0.02% | -10.5% |
| Q4 2022 | $856 | -99.9% | 21,667 | 0.0% | 0.02% | -9.5% |
| Q3 2022 | $871,000 | +48.9% | 21,667 | +55.7% | 0.02% | +50.0% |
| Q2 2022 | $585,000 | +69.1% | 13,920 | +56.9% | 0.01% | +40.0% |
| Q1 2022 | $346,000 | -2.3% | 8,871 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $354,000 | +58.7% | 8,871 | +73.8% | 0.01% | 0.0% |
| Q1 2021 | $223,000 | – | 5,104 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |